Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

MARK4 anticorps (C-Term)

MARK4 Reactivité: Humain WB Hôte: Chèvre Polyclonal unconjugated
N° du produit ABIN374191
  • Antigène Voir toutes MARK4 Anticorps
    MARK4 (MAP/microtubule Affinity-Regulating Kinase 4 (MARK4))
    Épitope
    • 16
    • 15
    • 13
    • 8
    • 8
    • 6
    • 4
    • 2
    • 1
    • 1
    • 1
    • 1
    C-Term
    Reactivité
    • 49
    • 39
    • 3
    Humain
    Hôte
    • 61
    • 1
    • 1
    Chèvre
    Clonalité
    • 62
    • 1
    Polyclonal
    Conjugué
    • 24
    • 6
    • 6
    • 6
    • 5
    • 5
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp MARK4 est non-conjugé
    Application
    • 49
    • 42
    • 13
    • 13
    • 11
    • 7
    • 5
    • 3
    • 2
    • 1
    • 1
    • 1
    Western Blotting (WB)
    Séquence
    IKRKPPPGCS DSPGV
    Specificité
    This antibody detects MARK4 at C-term.
    Purification
    Ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide
    Immunogène
    Peptide from the C Terminus of the protein sequence according to NP_113605.2. Genename: MARK4
    Top Product
    Discover our top product MARK4 Anticorps primaire
  • Indications d'application
    Peptide ELISA: Limit dilution 1: 128000. Western blot: 0.3-1 μg/mL. Approx 70 kDa band observed in human prostate lysates(calculated MW of 75.0 kDa according to NP_113605.2).
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.
    Restrictions
    For Research Use only
  • Concentration
    0.5 mg/mL
    Buffer
    Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Conseil sur la manipulation
    Avoid repeated freezing and thawing.
    Stock
    4 °C/-20 °C
    Stockage commentaire
    Store at 2 - 8 °C for up to one month or (in aliquots) at -20 °C.
  • Antigène
    MARK4 (MAP/microtubule Affinity-Regulating Kinase 4 (MARK4))
    Autre désignation
    MARK4 (MARK4 Produits)
    Synonymes
    anticorps MARK4, anticorps MARK4L, anticorps MARK4S, anticorps MARKL1, anticorps MARKL1L, anticorps PAR-1D, anticorps 2410090P21Rik, anticorps C79806, anticorps Markl1, anticorps microtubule affinity regulating kinase 4, anticorps MAP/microtubule affinity regulating kinase 4, anticorps MARK4, anticorps Mark4
    Sujet
    MARK4 contains an N terminal serine/threonine kinase domain, a central ubiquitin associated domain, and a C terminal KA1 associated kinase domain. RT PCR analysis detects upregulated expression of the gene for MARK4 in nearly all clinical hepatocellular carcinoma cells. Northern blot analysis reveals ubiquitous expression of a 3.6kb transcript, with highest expression in testis. Immunofluorescence microscopy demonstrates homogeneous cytoplasmic expression. Colony forming assays show that MARK4 antisense reduces the growth of SNU475 cells. It has been suggested that MARK4 provides a growth advantage to cells.Synonyms: MAP microtubule affinity-regulating kinase 4, MARKL1
    ID gène
    57787
    NCBI Accession
    NP_113605
    UniProt
    Q96L34
Vous êtes ici:
Support technique